Regiocit, Hämofiltrationslösung

7680665060019 CH-66506 Hämofiltrationslösung
Regiocit, Hämofiltrationslösung
Regiocit, Hämofiltrationslösung
Regiocit, Hämofiltrationslösung
1 / 3
google

Article details

Package size
2 x 5000
Selling units
2
Measure
ml
Galenic form
Hämofiltrationslösung
Galenic group
Dialyse

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
11/12/2025
Summary of Product Characteristics
Français
11/12/2025
Summary of Product Characteristics
Italien
11/12/2025

Detailed composition

Substance Quantity Type Category
natrii citras dihydricus
5.29 G Substance Wirkstoff (Principe actif)
natrii chloridum
5.03 G Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
140.0 MMOL Substance WIZUS
chloridum
86.0 MMOL Substance WIZUS
citras
18.0 MMOL Substance WIZUS

Authorization holder

Vantive GmbH

8152 Opfikon

Authorization information

Swissmedic authorization number
66506
Drug name
Regiocit, Hämofiltrationslösung
Galenic form
HAFL
ATC Code
B05ZB
Authorization status
Z
Dispensing category
B
First authorization
18/07/2018
Authorization expiration date
31/12/9999
IT Number
05.04.0.
Domain
Human medicine
Field of application
Substitutionslösung während kontinuierlicher Nierenersatztherapien (CRRT) im Zuge einer regionalen Citrat-Antikoagulation

Package details

Description (FR)
REGIOCIT sol 140 mmol 2x5000 ml
Description (DE)
REGIOCIT Lös 140 mmol 2x5000 ml
Market launch
01/03/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data